Tristan Edwards is an investment professional and Co-founder, President and Chief Investment Officer of Life Biosciences. This US biotech start-up is researching potential treatments to improve human healthspan.

Tristan Edwards is Proto Axiom's Executive Chairman. Tristan has had a 25–year career, highlighted by co-founding and first CEO of Boston-based Life Biosciences, the world’s leading human longevity company, making drugs to treat causes of aging.

He previously spent 18 years global funds management experience spanning Australia, London, Hong Kong, and Singapore, trading all asset classes with a focus on Asian equities (Goldman Sachs Asset Management, Brevan Howard Asset Management, Trafalgar Capital, Mosaic Asset Management).